G. A. M. de Vaan

596 total citations
30 papers, 470 citations indexed

About

G. A. M. de Vaan is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G. A. M. de Vaan has authored 30 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 9 papers in Immunology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G. A. M. de Vaan's work include Acute Lymphoblastic Leukemia research (15 papers), Acute Myeloid Leukemia Research (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). G. A. M. de Vaan is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Acute Myeloid Leukemia Research (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). G. A. M. de Vaan collaborates with scholars based in Netherlands, United States and Belgium. G. A. M. de Vaan's co-authors include J. A. J. M. Bakkeren, T. W. J. Hustinx, K. Hählen, P.J.J. Van Munster, J.F. van der Weerden, A van der Does-van den Berg, J. M. J. C. Scheres, Roland Holland, A. Veerman and E Schretlen and has published in prestigious journals such as Cancer, Biochemical Pharmacology and British Journal of Haematology.

In The Last Decade

G. A. M. de Vaan

29 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. A. M. de Vaan Netherlands 13 201 153 136 84 77 30 470
Yuri Okimoto Japan 10 135 0.7× 193 1.3× 106 0.8× 77 0.9× 30 0.4× 27 440
A Oakhill United Kingdom 12 167 0.8× 283 1.8× 94 0.7× 115 1.4× 42 0.5× 21 590
R Rokicka-Milewska Poland 12 70 0.3× 188 1.2× 64 0.5× 56 0.7× 101 1.3× 55 490
Sema Anak Türkiye 16 128 0.6× 193 1.3× 94 0.7× 150 1.8× 123 1.6× 73 629
Ömer Devecioğlu Türkiye 14 116 0.6× 164 1.1× 65 0.5× 116 1.4× 91 1.2× 59 482
Maria Luisa Moleti Italy 16 260 1.3× 251 1.6× 150 1.1× 225 2.7× 125 1.6× 65 737
Stavros Haidas Greece 12 61 0.3× 87 0.6× 55 0.4× 55 0.7× 39 0.5× 17 299
Alexandra Kolenová Slovakia 10 122 0.6× 136 0.9× 43 0.3× 71 0.8× 77 1.0× 40 332
Grazia Bossi Italy 13 59 0.3× 80 0.5× 59 0.4× 53 0.6× 111 1.4× 42 486
Youcef Chelghoum France 12 180 0.9× 269 1.8× 60 0.4× 151 1.8× 134 1.7× 35 466

Countries citing papers authored by G. A. M. de Vaan

Since Specialization
Citations

This map shows the geographic impact of G. A. M. de Vaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. A. M. de Vaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. A. M. de Vaan more than expected).

Fields of papers citing papers by G. A. M. de Vaan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. A. M. de Vaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. A. M. de Vaan. The network helps show where G. A. M. de Vaan may publish in the future.

Co-authorship network of co-authors of G. A. M. de Vaan

This figure shows the co-authorship network connecting the top 25 collaborators of G. A. M. de Vaan. A scholar is included among the top collaborators of G. A. M. de Vaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. A. M. de Vaan. G. A. M. de Vaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szczepański, Tomasz, G. A. M. de Vaan, Auke Beishuizen, et al.. (2003). Acute lymphoblastic leukemia followed by a clonally‐unrelated EBV‐positive non‐Hodgkin lymphoma and a clonally‐related myelomonocytic leukemia cutis. Pediatric Blood & Cancer. 42(4). 343–349. 10 indexed citations
2.
Kamps, Willem A., J.P.M. Bökkerink, K. Hählen, et al.. (1999). Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).. PubMed. 94(4). 1226–36. 83 indexed citations
3.
Vaan, G. A. M. de, et al.. (1996). CD4 deficiency in myelodysplastic syndrome with monosomy 7. European Journal of Pediatrics. 155(2). 96–98. 2 indexed citations
4.
Berg, A van der Does-van den, G. A. M. de Vaan, J.F. van der Weerden, et al.. (1995). Late Effects among Long-Term Survivors of Childhood Acute Leukemia in The Netherlands: A Dutch Childhood Leukemia Study Group Report. Pediatric Research. 38(5). 802–807. 30 indexed citations
5.
Vaan, G. A. M. de, et al.. (1994). Juvenile xanthogranuloma and acute leukemia: A case report. Medical and Pediatric Oncology. 23(1). 57–59. 13 indexed citations
6.
Haraldsson, Ásgeir, et al.. (1994). Light Chain Ratios and Concentrations of Immunoglobulins G, A, And M in Childhood Common Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology. 11(1). 83–90. 7 indexed citations
7.
Vaan, G. A. M. de, et al.. (1992). Iatrogenic IgG2 deficiency in a leukaemic child. European Journal of Pediatrics. 151(4). 271–273. 1 indexed citations
8.
Wit, P.E.J. de, et al.. (1990). Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Medical and Pediatric Oncology. 18(4). 336–338. 32 indexed citations
9.
Veerman, A., K. Hählen, W. A. Kamps, et al.. (1990). Dutch Childhood Leukemia Study Group: Early Results of Study ALL VI (1984–1988). Hämatologie und Bluttransfusion. 33. 473–477. 27 indexed citations
10.
Vaan, G. A. M. de, et al.. (1989). Mild course of mumps in patients with acute lymphoblastic leukaemia. European Journal of Pediatrics. 148(7). 618–619. 8 indexed citations
11.
Abreu, Ronney A. De, et al.. (1986). 6-Mercaptopurine: Total Body Autoradiograms and Plasma Concentration-Time Curves of 6MP and Metabolites from Marmoset Monkeys. Pediatric Hematology and Oncology. 3(2). 159–165. 3 indexed citations
13.
Gerrits, G. P. J. M., et al.. (1984). Transient erythroblastopenia of childhood. European Journal of Pediatrics. 142(4). 266–270. 26 indexed citations
14.
Abreu, Ronney A. De, et al.. (1984). 6-Mercaptopurine: Pharmacokinetics in Animals and Preliminary Results in Children. Advances in experimental medicine and biology. 165 Pt B. 367–370. 15 indexed citations
15.
Vaan, G. A. M. de, et al.. (1982). THE APLASTIC PRESENTATION OF CHILDHOOD LEUKAMEIA. British Journal of Haematology. 50(4). 712–713. 9 indexed citations
16.
Vaan, G. A. M. de, P.J.J. Van Munster, & J. A. J. M. Bakkeren. (1982). Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood. European Journal of Pediatrics. 139(2). 113–117. 32 indexed citations
17.
Vaan, G. A. M. de, et al.. (1980). Histiocytosis X. European Journal of Pediatrics. 135(2). 129–146. 18 indexed citations
18.
Vaan, G. A. M. de, et al.. (1979). Palmar flexion creases in childhood neoplasia. Cancer. 43(2). 749–759. 12 indexed citations
19.
Scheres, J. M. J. C., et al.. (1978). 15/17 Translocation in acute promyelocytic leukaemia. Human Genetics. 43(1). 115–117. 28 indexed citations
20.
Rotteveel, Jan J., et al.. (1977). Glucosephosphate isomerase deficiency, a new variant in a dutch family. European Journal of Pediatrics. 125(1). 21–28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026